Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9310825rdf:typepubmed:Citationlld:pubmed
pubmed-article:9310825lifeskim:mentionsumls-concept:C1420192lld:lifeskim
pubmed-article:9310825lifeskim:mentionsumls-concept:C1326163lld:lifeskim
pubmed-article:9310825pubmed:issue9lld:pubmed
pubmed-article:9310825pubmed:dateCreated1997-10-28lld:pubmed
pubmed-article:9310825pubmed:abstractTextCD98 is a 125 kDa heterodimer, which is strongly expressed on the surface of activated and proliferating cells. Its expression is strikingly regulated during T cell differentiation and activation, but the role of CD98 during T lymphocyte responses is not yet understood. We report here that proliferation of resting peripheral blood mononuclear cells (PBMC) induced by lectin, superantigen (SAg) or conventional antigens was blocked by anti-CD98 heavy chain (CD98hc) mAb. In contrast, anti-CD98hc did not block responses of T cell clones or lines. Anti-CD98hc inhibited IL-2 receptor expression and progression of T cells from G1 to S phase, but did not reduce expression of the IL-2 gene. Anti-CD98hc mAb did not regulate the initial activation events involving the TCR and co-receptor structures, but instead inhibited T lymphocyte responses even when added 18 h or more after the activation stimulus. Further experiments demonstrated that anti-CD98 was not directly affecting T cells in this system, but was instead acting on accessory cells. This was supported using a novel xenogeneic system that takes advantage of the lack of xenoreactivity of purified human T cells against mouse splenocytes. Despite absence of a direct xenoresponse to murine spleen cells, human T cells were activated by SAg presented by murine splenic antigen-presenting cells (APC). Murine anti-human CD98hc did not block T cell proliferation in this system. Furthermore, responses using monocyte-depleted PBMC as APC were not blocked by anti-CD98hc. Taken together, the present data suggests that triggering of human monocyte CD98 can suppress T cell proliferation by a process that halts progression through the cell cycle of recently activated T lymphocytes. This may represent a novel pathway for monocyte regulation of T cell activation.lld:pubmed
pubmed-article:9310825pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:languageenglld:pubmed
pubmed-article:9310825pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:citationSubsetIMlld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9310825pubmed:statusMEDLINElld:pubmed
pubmed-article:9310825pubmed:monthSeplld:pubmed
pubmed-article:9310825pubmed:issn0953-8178lld:pubmed
pubmed-article:9310825pubmed:authorpubmed-author:HUHHlld:pubmed
pubmed-article:9310825pubmed:authorpubmed-author:HanashS MSMlld:pubmed
pubmed-article:9310825pubmed:authorpubmed-author:OTAM IMIlld:pubmed
pubmed-article:9310825pubmed:authorpubmed-author:KuickR DRDlld:pubmed
pubmed-article:9310825pubmed:authorpubmed-author:FriedmanA WAWlld:pubmed
pubmed-article:9310825pubmed:authorpubmed-author:DiazL ALAJrlld:pubmed
pubmed-article:9310825pubmed:issnTypePrintlld:pubmed
pubmed-article:9310825pubmed:volume9lld:pubmed
pubmed-article:9310825pubmed:ownerNLMlld:pubmed
pubmed-article:9310825pubmed:authorsCompleteYlld:pubmed
pubmed-article:9310825pubmed:pagination1221-31lld:pubmed
pubmed-article:9310825pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:meshHeadingpubmed-meshheading:9310825-...lld:pubmed
pubmed-article:9310825pubmed:year1997lld:pubmed
pubmed-article:9310825pubmed:articleTitleMonocyte-dependent regulation of T lymphocyte activation through CD98.lld:pubmed
pubmed-article:9310825pubmed:affiliationRackham Arthritis Research Unit, Department of Internal Medicine, Specialized Center of Research in Rheumatoid Arthritis, Ann Arbor, MI, USA.lld:pubmed
pubmed-article:9310825pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9310825pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9310825pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9310825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9310825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9310825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9310825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9310825lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9310825lld:pubmed